Purinergic Signaling in Neuroinflammation

• Ētahi atu kaituhi: Aminin, Dmitry (Editor), Illes, Peter (Editor)
• Hōputu: Tāhiko Wāhanga pukapuka
• Reo: Ingarihi
• I whakaputaina: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Ngā marau: Research & information: general; Biology, life sciences; adenosine receptors; adipogenesis; osteogenesis; adipose tissue; bone marrow; obesity; neonatal seizures; development; ATP; purinergic signalling; P2X7 receptor; endometriosis; adenosine; P2Y; P2X; ectonucleotidases; pain; inflammation; endometrium; CD73; CD39; P2Y2 receptor; P2X4 receptor; canine; dog; DH82; macrophage; neuroinflammation; antinociception; cerebral ischemia; oxygen-glucose deprivation; A2B receptors; oligodendrocyte differentiation; demyelination; retina; purinergic modulation; glycinergic neurotransmission; microglia; neurodegeneration; glycine transporters; guanosine; stroke; neuroprotection; purinergic signaling; purinergic receptors; autoimmune disease; astroglia; G protein-coupled receptor 17 (GPR17); neurite outgrowth; montelukast; NG2; ex vivo organotypic brain slice co-culture; neurodegeneration and neuroregeneration; n/a; macrophages; P2X7R; pore formation; inflammasome activation; inflammatory diseases; gallic acid; visceral pain; depression; hippocampus; spinal cord; dorsal root ganglion
• Urunga tuihono: DOAB: download the publication; DOAB: description of the publication

It is currently apparent that extracellular ATP's physiological effect is mediated by its interaction with specific purinergic receptors. All purinergic receptors are divided into P1-purinoreceptors and P2-purinoreceptors. Each of the subtypes is divided into a number of families. For instance,...